AbbVie
AbbVie is a global biopharmaceutical company focused on discovering, developing, and delivering advanced therapies across key therapeutic areas such as immunology, oncology, neuroscience, and eye care. Formed in 2013 as a spin-off from Abbott Laboratories, AbbVie is a leading player in the pharma industry with a strong portfolio of branded drugs and a significant pipeline. The company operates in over 175 countries and employs more than 40,000 people worldwide. Its products span both small molecules and biologics, with a substantial focus on specialty treatments.
Company History
AbbVie was created in January 2013 as a tax-free spin-off of Abbott Laboratories' research-based pharmaceuticals business. Since its inception, it has grown rapidly through both organic R&D and strategic acquisitions, most notably the nearly $63 billion acquisition of Allergan in 2020, which added a strong medical aesthetics portfolio (including the Botox franchise) to its offerings. Today, AbbVie is one of the world's top pharmaceutical companies by revenue.
For International Professionals
- AbbVie Spain, headquartered in Madrid, runs international operations from its Spanish office, with a significant presence across the Peninsula.
- The company offers Beca (internship) programs for Spanish and EU residents, providing a direct entry into the pharma sector for early-career professionals.
- Working at AbbVie Spain provides exposure to a global portfolio of specialty medicines and collaborations with diverse teams across Europe.
- AbbVie frequently recruits for sales, medical affairs, and market access roles, which involve cross-functional interplay and offer a holistic understanding of the EU pharma ecosystem.
- There are likely international career progression paths as AbbVie has a global structure, especially through roles in marketing, medical affairs, and management within its Spanish subsidiary.
- initiative_mentions_in_naics_codes